Table 3.

Allele and genotype frequencies of common variants of CFHR5 in patients with IgAN and healthy controls

Variants	Allele Frequencies		Genotype Frequencies
c.58+17 T>A	A	T	AA + AT	TT
IgAN	140 (14.00%)	860 (86.00%)	15+110 (25.00%)	375 (75.00%)
HC	163 (14.10%)	989 (85.90%)	7+149 (27.10%)	420 (72.90%)
P value	0.92		0.44
c.431–80 G>A	A	G	AA + AG	GG
IgAN	13 (1.30%)	987 (98.70%)	0+13 (2.60%)	487 (97.40%)
HC	15 (1.30%)	1137 (98.70%)	0+15 (2.60%)	561 (97.40%)
P value	>0.99		>0.99
c.434 G>A	A	G	AA + AG	GG
IgAN	13 (1.30%)	987 (98.70%)	0+13 (2.60%)	487 (97.40%)
HC	15 (1.30%)	1137 (98.70%)	0+15 (2.60%)	561 (97.40%)
P value	>0.99		>0.99
c.1147+24 T>G	G	T	GG + GT	TT
IgAN	332 (33.20%)	668 (66.80%)	61+210 (54.20%)	229 (45.80%)
HC	364 (31.60%)	788 (68.40%)	49+266 (54.70%)	261 (45.30%)
P value	0.43		0.87

HC, healthy controls.